Delivery Order SPE2DB20D1109-SPE2DB25FP37N
- Not listed
- The Defense Logistics Agency awarded a $1,290.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for XTAMPZA ER 9 mg capsules (100-count units) with an ultimate completion date of July 31, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for XTAMPZA ER 18 mg capsules (100-count packages) valued at $6,281.84 under a firm fixed-price contract type. The award was made on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,299.87 to AmerisourceBergen Drug Corp for XTAMPZA ER CAPS 13.5MG, a pharmaceutical product. The contract was competitively awarded without a set-aside designation on April 23, 2025, with an ultimate completion date of April 24, 2025. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. The award employs firm fixed price terms, typical of delivery orders...
- The Defense Logistics Agency awarded a $1,218.07 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Xtampza ER 27 mg capsules (100-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 13, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Department of Defense Medical Supply Chain awarded a delivery order valued at $9,654.96 to AmerisourceBergen Drug Corp for XTAMPZA ER CAPS 36MG, a pharmaceutical product. This firm fixed price delivery order, issued on July 14, 2025, represents a child contract under a larger indefinite delivery vehicle and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 15, 2025. The award was competitively awarded...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,837.82 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is for the supply of XTAMPZA ER 36 MG CAPSULE 100S, a type of medication. This delivery order contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,158,451 units of the pharmaceutical product XTAMPZA ER CAPS 27MG. The $3,833.76 contract has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is associated with a larger $999,999,999.00 indefinite delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,959.19 firm fixed-price delivery order is for 4566295836 XTAMPZA ER 27 MG CAPSULE 100S, a specialty medication. The contract has an ultimate completion date of November 1, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xtampza ER 27 mg capsules (100-count units) on September 12, 2025, with a ceiling value of $1,092.43. This firm fixed price delivery order has an ultimate completion date of September 15, 2025, and represents a non-competitive award under a larger contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's Conshohocken, Pennsylvania facility, which serves as the company's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of XTAMPZA ER CAPS 36MG. The award has a ceiling value of $5,229.60 and an ultimate completion date of August 14, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP37NDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,085.35 for XTAMPZA ER 18 mg capsules (100-count units) on July 11, 2025, with an ultimate completion date of July 14, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA prime contract serves as a comprehensive global pharmaceutical support vehicle enabling delivery of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for XTAMPZA represents one of numerous pharmaceutical transactions executed under this expansive IDC, demonstrating the company's continued role as a key supplier within the Defense Health Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/11/25 |